Global Motion Sickness Treatment Market to Reach $863.2 Million by 2030
The global market for Motion Sickness Treatment estimated at US$741.2 Million in the year 2022, is projected to reach a revised size of US$863.2 Million by 2030, growing at a CAGR of 1.9% over the analysis period 2022-2030. Anticholinergic, one of the segments analyzed in the report, is projected to record 2.2% CAGR and reach US$532.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Antihistamines segment is readjusted to a revised 1.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $198 Million, While China is Forecast to Grow at 3.7% CAGR
The Motion Sickness Treatment market in the U.S. is estimated at US$198 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$176.1 Million by the year 2030 trailing a CAGR of 3.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.3% and 1.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 0.8% CAGR.Select Competitors (Total 47 Featured) -
- Baxter International, Inc.
- Caleb Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Myungmoon Pharma Co. Ltd.
- Perrigo Company PLC
- Prestige Brands, Inc.
- Reliefband Technologies LLC
- Wellspring Pharmaceutical Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter International, Inc.
- Caleb Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Myungmoon Pharma Co. Ltd.
- Perrigo Company PLC
- Prestige Brands, Inc.
- Reliefband Technologies LLC
- Wellspring Pharmaceutical Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 197 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 741.2 Million |
Forecasted Market Value ( USD | $ 863.2 Million |
Compound Annual Growth Rate | 1.9% |
Regions Covered | Global |